Table 4.
Characteristics | NSTEMI (N = 6366) | STEMI (N = 4679) | Total (N = 11,045) a |
---|---|---|---|
Success of monitoring at PH 3 months | 5608 (89.1%) | 4155 (90.6%) | 9763 (89.7%) |
Drug adherence at PH 3 months b | |||
Low adherence (score >= 4) | 32 (0.6%) | 26 (0.6%) | 58 (0.6%) |
High adherence (score < 4) | 5459 (99.4%) | 4037 (99.4%) | 9496 (99.4%) |
Participation in second rehabilitation | 831 (14.4%) | 860 (19.8%) | 1691 (16.8%) |
No return to work or daily life until PH 3 months | 360 (6.4%) | 185 (4.5%) | 545 (5.6%) |
Success of monitoring at PH 12 months | 4749 (82.3%) | 3711 (87.6%) | 8460 (84.5%) |
Drug adherence at PH 12 months b | |||
Low adherence (score >= 4) | 16 (0.3%) | 17 (0.5%) | 33 (0.4%) |
High adherence (score < 4) | 4646 (99.7%) | 3629 (99.5%) | 8275 (99.6%) |
All cause death from discharge during PH 3 months | 124 (1.9%) | 81 (1.7%) | 205 (1.9%) |
All cause death from discharge during PH 12 months | 326 (5.1%) | 158 (3.4%) | 484 (4.4%) |
Type of death | |||
Cardiovascular | 114 (35.0%) | 52 (32.9%) | 166 (34.3%) |
Non-cardiovascular | 111 (34.0%) | 52 (32.9%) | 163 (33.7%) |
Unknown | 101 (31.0%) | 54 (34.2%) | 155 (32.0%) |
AMI re-event during PH 12 month | 174 (2.9%) | 75 (1.7%) | 249 (2.4%) |
Cerebrovascular event during PH 12 month | 60 (1.0%) | 19 (0.4%) | 79 (0.8%) |
Heart failure event during PH 12 month | 116 (1.9%) | 69 (1.6%) | 185 (1.8%) |
Above BARC 2 Bleeding event during PH 12 month | 88 (1.5%) | 51 (1.2%) | 139 (1.3%) |
NSTEMI: Non-ST elevation myocardial infarction; STEMI: ST elevation myocardial infarction; PH: Post Hospital, BARC: Bleeding Academic Research Consortium. a Among registered 11,894 patients, 136 were excluded because they died or were transferred to another hospital prior to diagnosis, and 660 were excluded because they died at hospital. b Results by Morisky Medication Adherence Scale, which consists of 6 questions (yes/no) items and so scores range 0 to 6.